DBT smartphone app by Monsenso will be implemented by the end of August
Copenhagen, Denmark – 18 July 2017 Monsenso, a Danish developer in mobile health solutions for mental health, has announced that Datlinien, a private clinic in Denmark, will soon implement the Monsenso mHealth solution with an added Dialectical Behavioural Therapy (DBT) module.
DBT is an evidence-based treatment that is commonly used to treat Borderline Personality Disorder.
Online-based DBT solutions have been found to make treatment easier to manage for clinicians, by storing information in an easily accessible place through cloud technology.
A new DBT module was recently added to the Monsenso mHealth solution as part of the mDiary Study, a research project done in collaboration with several Danish partners. The Monsenso mHealth solution, which consists of a smartphone app for individuals and a web portal for clinicians, provides a reliable, efficient, and clinically-validated smartphone based approach to DBT.
Some of the key factors of DBT include skills training and self-monitoring, which have been administered traditionally through paper-based self-assessments, workbooks and diaries. The Monsenso DBT smartphone app helps optimise and organise this process, by putting self-assessments, self-monitoring, skills training, emotion rating, and synchronized clinician feedback into one convenient location – your smartphone.
Datlinien offers mental health services, with a special focus on DBT, to public and private institutions, and they provide DBT treatment for both group and individual therapy.
Thomas Lethenborg, CEO at Monsenso, said “This new DBT module was developed as part of the mDiary Study to complement the treatment of individuals undergoing DBT treatment. It was designed to modernise the traditionally used paper-based assessments and skills training, and to make it more intuitive.”
Dr. Shahram Elahi Panah, General Manager of Datlinien, said “By adopting this new technology, we want to raise the bar on the mental health services offered by private clinics in Denmark. The Monsenso DBT smartphone app makes data collection and skills training more fun and interactive, which is great for the patients because it increases compliance and engagement. On the other hand, it is also great for us, the clinicians, because we can visualise all the patient data more easily.”
Click on the link to read the press release in Danish.
For additional information contact:
+45 30 25 15 26
Copenhagen, Denmark – 28 June 2017. The IMPACHS project funded by Eureka/Eurostars and the Innovation Fund in Demark, has the aim to design, develop and provide clinical evidence for the use of smartphone-based intervention technology for outpatients diagnosed with schizophrenia, to improve the availability and cost-effectiveness of mental healthcare.
The project, with a duration of 24 months (June 2017 – June 2019) and a total budget of 1.2 million Euros, brings together leading European research/academic institutions and SMEs.
The IMPACHS project (IMProving Availability and Cost-effectiveness of mental Healthcare for Schizophrenia through mHealth), is done in collaboration between Monsenso, the Psychiatric Research Unit from Region Zealand, time4you, and the University of Hamburg.
Cognitive Behavioural Therapy (CBT) is one of the most effective psychological approaches for psychotic symptom reduction, but only 10% of patients receive it due to growing shortage of professionals . Mobile-based CBT interventions (mCBT), as an adjunct to traditional care, provide a unique opportunity to deliver continuous, cost-effective, accessible, non-stigmatizing and timely support to these patients, promoting the detection of alarming symptoms and reducing the duration of relapses, observed in 80% of patients.
The IMPACHS project aims to develop mobile- and context-aware CBT content, deployed through the time4you IBT® SERVER (eLearning) platform integrated into the Monsenso Clinic mHealth solution for mental illnesses that is HIPAA compliant and has a class 1 CE & TGA mark.
The staff at the University of Hamburg have extensive knowledge on using CBT for individuals with schizophrenia and has published several research papers in medical journals related to schizophrenia. The project will leverage their substantial experience in clinical research within schizophrenia to develop the assessments and interventions planned.
The Psychiatric Research Unit of the Zealand Region of Denmark will begin the trial using an improved version of the Monsenso Clinic that offers psycho-education through the integrated IBT e-learning platform that delivers continuous, cost-effective, and timely support to individuals with schizophrenia, complementing their therapy.
Personalised triggers, defined jointly by individuals and therapists based on a person’s behaviours, can be used to detect symptom aggravation in real-time. Mobile CBT can help lower the severity of a person’s symptoms if the content is personalised and disorder-specific.
The objective of the clinical trial is to determine the feasibility of context-aware CBT and psycho-educative content in the users’ recovery process.
With regards to the clinical trial, Thomas Lethenborg, CEO at Monsenso, commented, “Mobile-based CBT and psychoeducation is a cost-efficient solution to complement a person’s treatment. In some cases, it might be the only type of therapy that some people might be able to access, depending on the waiting list for the mental health services, and their financial or geographical situation. This type of solution may be the best way to reach more people at a lower cost.”
Dr. Hartwig Holzapfel, Director of Professional Services, said “IMPACHS opens new ways for outpatient psychotherapy and patient education. With new individualized solutions that include learning analytics and adaptive learning, patients are empowered and gain faster access and better education. Mobile Health solutions are an economical and cost-efficient way of treatment and form an important building block of modern healthcare. Within the IMPACHS-project, time4you is responsible for the technical solution based on the IBT SERVER-software, system integration, and supports partners in developing content with methodical, didactical, medical and technical expertise.”
Click on the links to read the press release in Danish
 Bucci et al (2015) Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial. Trials 16:404
 Alvarez-Jimenez et al (2014) Online, social media and mobile technologies for psychosis treatment: A systematic review on novel user-led interventions. Schizophrenia Research 156 (2014) 96–106
 NICE Guidelines. Psychosis and schizophrenia in adults: treatment and management, [CG178]. London: Excellence NIfHaC; 2014.
For additional information contact:
Marketing and Communications Manager
+45 30 25 15 26
+49 172 208 43 58
The ROI on mobile health apps is critical to ensure the feasibility and long-term success of digital initiatives implemented by a healthcare institution. On a previous blog post titled “Patient engagement – How important are mHealth tools?” we pointed out the importance for healthcare institutions to embrace mHealth technology if they want to meet consumers’ requirements.
A recent survey revealed that:
- 80% of internet connected adults use some form of digital health technology
- 52% of consumers strongly agree they are responsible for their own health
- 40% of people who made an online search for health information acted on the results of their search in some way
- 92% of users agree that they should be the one controlling their health data
- 80% of users would share their health data with their care provider to get better care 
Furthermore, a report from a Swedish market research firm forecasts that by 2021, there will be 50.2 million patients monitored remotely, of which 22.9 million will be monitored remotely using their own smartphone. 
By boasting the consumers’ use of certified, clinically and technically validated mobile health apps, organisations could potentially have huge cost-savings in four particular areas.
- Addressing chronic illnesses: providing mobile health apps to people with chronic diseases such as heart disease, diabetes, and mental illness, can be a great way continuously monitor the symptoms and spot any relapses.
- Avoiding non-urgent use of the ER: the use of mobile health apps enable continuous monitoring and early Therefore the trips to the emergency rooms can be prevented by scheduling preventive consultations based on the data collected by the health app
- Reducing preventable readmissions: A study conducted by the Mayo Clinic showed that there was a 40% decrease in readmission for patients with heart disease who used a specific health app. The RADMIS research project, which is being conducted in Denmark using the Monsenso mhealth solution, aims to reduce hospital readmissions of psychiatric patients by 50%
- Improving prescription adherence: A review in the Annals of Internal Medicine estimates that a lack of medication adherence causes nearly 125,000 deaths, 10% of hospitalisations and costs the US economy between $100 to $289 billion per year . Mobile health apps can be used to help improve adherence rates.
As more healthcare institutions embrace mHealth initiatives, it is important to take into consideration certain aspects to secure an optimal return on investment and ensure long-term success.
Prioritise strategically and secure C-suite support:
Aligning mobile health initiatives with an organisation’s business goals helps achieve ROI on mHealth solutions and better outcomes in the long run, and it also helps obtain the support of the organisation’s decision-makers. When an organisation’s mHealth initiatives are aligned with the overall strategy, this will also contribute to ensuring that the technology is rolled out on a large scale, instead of being implemented as small independent projects with a limited impact.
Furthermore, when selecting and implementing an mHealth initiative, it is critical to involve both employees (because they will be using the system daily) and management, since it is up to the latter to ensure all employees understand the process involved in the roll-out, allocate budget and/or time for special training, and make the necessary changes to the organisational processes.
Healthcare institutions that take a strategic approach by scaling internal resources across their organisations are more likely to make use of the transformational aspects of the technology. Instead of limiting mobile projects to a particular department, mobile health initiatives should be integrated throughout the entire organisation and become embraced as part of the organisation’s culture.
Utilise a mix of customised and off-the-shelf solutions:
Recognising when to select customised solutions and when to opt for existing mobile health solutions will help an organisation operate strategically and focus on business transformation.
According to a study by the IBM Institute for Business Value “More than 1,000 C-suite and mobile executives globally found that 62% of executives surveyed said their most successful mobile projects pay for themselves in less than 12 months – a considerably faster rate than the two-to-three years it takes for other technology projects. ”
 Rock Health: 80 percent of internet-connected adults use digital health tools. J. Comstock. MobiHealthNews. (2015, October 19)
 MHealth and Home Monitoring. Berg Insight. 2015.
 The cost of medication non-adherence. NACD. (2017, April 20)
 IBM Study: Four Ways to Achieve Maximum ROI in Enterprise Mobility. IBM News. (2017, April 22)